25.05.2017 - The UK’s Competition and Markets Authority (CMA) has provisionally ruled that a discount scheme operated by US drugmaker Merck for Remicade may have broken competition rules by...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)